ALPINE, UT, Sept. 16, 2014 /PRNewswire/ - American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products. The new products will allow American Biotech Labs (ABL) to market in the wound-care market focusing on ultimate sports and fitness, spa and health, and animal markets.
The new over-the-counter (OTC) products will have wound-dressing claims for minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations. The products also have pathogen-inhibiting barrier claims against pathogens, such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, MRSA and VRE, as well as fungi, such as Candida albicans and Aspergillus niger. These new gels can provide a barrier that will help protect wounds for 24 to 72 hours.
The new products will be found under the names of Armor Gel™ (for the ultimate sports and fitness market), ASAP OTC™ (for the spa and health markets), and ASAP Pet Shield® (for the animal market).
Along with the release of these new products, ABL has formed a strategic alliance with Stuart Evey, founder and former chairman of ESPN, and Gary Bernstein, marketing executive and professional photographer and film maker. ABL will utilize these talented individuals to help introduce these revolutionary new products to high-profile organizations in sports, pet stores, fashion and beauty, medical, and direct-marketing areas, etc.
Said Keith Moeller, ABL Director, "We are very grateful to the numerous top scientists, labs and universities that have helped move this amazing, patented, silver technology forward. We believe that these products have the ability to impact the future of wound management worldwide."
Note: Any statements released by American Biotech Labs, LLC that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance.
SOURCE American Biotech Labs, LLC